ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 175 filers reported holding ANI PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $242,000 | -30.3% | 3,930 | -17.5% | 0.00% | – |
| Q3 2019 | $347,000 | -13.7% | 4,763 | -2.5% | 0.00% | -100.0% |
| Q2 2019 | $402,000 | +7.2% | 4,887 | -8.0% | 0.00% | 0.0% |
| Q1 2019 | $375,000 | -44.1% | 5,312 | -64.4% | 0.00% | 0.0% |
| Q4 2018 | $671,000 | -0.3% | 14,903 | +25.2% | 0.00% | 0.0% |
| Q3 2018 | $673,000 | -3.6% | 11,905 | +13.9% | 0.00% | 0.0% |
| Q2 2018 | $698,000 | -16.9% | 10,455 | -27.5% | 0.00% | -50.0% |
| Q1 2018 | $840,000 | -39.3% | 14,420 | -32.8% | 0.00% | -33.3% |
| Q4 2017 | $1,383,000 | +14.6% | 21,462 | -6.6% | 0.00% | +50.0% |
| Q3 2017 | $1,207,000 | +413.6% | 22,990 | +358.5% | 0.00% | +100.0% |
| Q2 2017 | $235,000 | -11.7% | 5,014 | -6.6% | 0.00% | 0.0% |
| Q1 2017 | $266,000 | -16.9% | 5,368 | +1.7% | 0.00% | 0.0% |
| Q4 2016 | $320,000 | -3.3% | 5,276 | +5.6% | 0.00% | 0.0% |
| Q3 2016 | $331,000 | – | 4,996 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 327,929 | $9,218,000 | 3.24% |
| Parkman Healthcare Partners LLC | 107,911 | $3,033,000 | 0.89% |
| Global Alpha Capital Management Ltd. | 350,231 | $9,845,000 | 0.85% |
| MARATHON CAPITAL MANAGEMENT | 75,010 | $2,109,000 | 0.60% |
| TANG CAPITAL MANAGEMENT LLC | 100,000 | $2,811,000 | 0.56% |
| EMERALD ADVISERS, LLC | 354,045 | $9,952,000 | 0.38% |
| Sio Capital Management, LLC | 40,000 | $1,124,000 | 0.37% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 299,493 | $8,419,000 | 0.37% |
| Stonepine Capital Management, LLC | 26,060 | $733,000 | 0.30% |
| Mitsubishi UFJ Asset Management (UK) Ltd. | 23,000 | $646,530,000 | 0.29% |